1-15 of 15
Peter Rossing, DMSC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes

Simone Theilade, MD, Maria Lajer, PHD, Frederik Persson, MD, Christel Joergensen, MD, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2013;36(3):715–721
https://doi.org/10.2337/dc12-0850
Published: 13 February 2013
View article titled, Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes
Open the PDF for Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes in another window
Journal Articles

Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate

Christel Joergensen, MD, Henrik Reinhard, MD, Anne Schmedes, PHD, Peter R. Hansen, DMSC, Niels Wiinberg, MD, Claus L. Petersen, MD, Kaj Winther, MD, Hans-Henrik Parving, DMSC, Peter K. Jacobsen, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2012;35(1):168–172
https://doi.org/10.2337/dc11-1372
Published: 09 December 2011
View article titled, Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate
Open the PDF for Vitamin D Levels and Asymptomatic Coronary Artery Disease in Type 2 Diabetic Patients With Elevated Urinary Albumin Excretion Rate in another window
Journal Articles

Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes

Christel Joergensen, MD, Peter Hovind, DMSC, Anne Schmedes, PHD, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2011;34(5):1081–1085
https://doi.org/10.2337/dc10-2459
Published: 20 April 2011
View article titled, Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes
Open the PDF for Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes in another window
Journal Articles

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy

Kasper Broedbaek, MD, Trine Henriksen, PHD, Allan Weimann, PHD, Morten Petersen, MD, Jon T. Andersen, MD, Shoaib Afzal, MD, Espen Jimenez-Solem, MD, Frederik Persson, MD, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC, Henrik E. Poulsen, DMSC
Journal: Diabetes Care
Diabetes Care 2011;34(5):1192–1198
https://doi.org/10.2337/dc10-2214
Published: 20 April 2011
View article titled, Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: <subtitle>An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy</subtitle>
Open the PDF for Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: <subtitle>An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy</subtitle> in another window
Includes: Supplementary data
Journal Articles

Osteoprotegerin and Mortality in Type 2 Diabetic Patients

Henrik Reinhard, MD, Maria Lajer, PHD, Mari-Anne Gall, DMSC, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Lars M. Rasmussen, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(12):2561–2566
https://doi.org/10.2337/dc10-0858
Published: 07 October 2010
View article titled, Osteoprotegerin and Mortality in Type 2 Diabetic Patients
Open the PDF for Osteoprotegerin and Mortality in Type 2 Diabetic Patients in another window
Journal Articles

Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy

Frederik Persson, MD, Julia B. Lewis, MD, Edmund J. Lewis, MD, Peter Rossing, DMSC, Norman K. Hollenberg, PHD, Hans-Henrik Parving, DMSC, for the AVOID Study Investigators
Journal: Diabetes Care
Diabetes Care 2010;33(11):2304–2309
https://doi.org/10.2337/dc10-0833
Published: 06 August 2010
View article titled, Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy
Open the PDF for Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy in another window
Includes: Supplementary data
Journal Articles

Vitamin D Levels and Mortality in Type 2 Diabetes

Christel Joergensen, MD, Mari-Anne Gall, DMSC, Anne Schmedes, PHD, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(10):2238–2243
https://doi.org/10.2337/dc10-0582
Published: 06 July 2010
View article titled, Vitamin D Levels and Mortality in Type 2 Diabetes
Open the PDF for Vitamin D Levels and Mortality in Type 2 Diabetes in another window
Journal Articles

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy

Maria Lajer, PHD, Anders Jorsal, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(7):1567–1572
https://doi.org/10.2337/dc09-2174
Published: 31 March 2010
View article titled, Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
Open the PDF for Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy in another window
Journal Articles

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

Frederik Persson, MD, Peter Rossing, DMSC, Henrik Reinhard, MD, Tina Juhl, Coen D.A. Stehouwer, MD, Casper Schalkwijk, PHD, A.H. Jan Danser, MD, Frans Boomsma, Erik Frandsen, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(10):1873–1879
https://doi.org/10.2337/dc09-0168
Published: 08 July 2009
View article titled, Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
Open the PDF for Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria in another window
Includes: Supplementary data
Journal Articles

Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy

Maria Lajer, MSC, Lise Tarnow, DMSC, Anders Jorsal, Tom Teerlink, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2008;31(4):747–752
https://doi.org/10.2337/dc07-1762
Published: 01 April 2008
View article titled, Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
Open the PDF for Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy in another window
Journal Articles

Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy

Peter Rossing, DMSC, Kasper Rossing, MD, Peter Gæde, MD, Oluf Pedersen, DMSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(5):1024–1030
https://doi.org/10.2337/dc05-2201
Published: 01 May 2006
View article titled, Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy
Open the PDF for Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy in another window
Journal Articles

Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy

Anne Sofie Astrup, MD, Lise Tarnow, DMSC, Peter Rossing, DMSC, Birgitte V. Hansen, Jannik Hilsted, DMSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(2):334–339
https://doi.org/10.2337/diacare.29.02.06.dc05-1242
Published: 01 February 2006
View article titled, Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
Open the PDF for Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy in another window
Journal Articles

Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes

Peter Hovind, MD, Lise Tarnow, DMSC, MD, Kasper Rossing, MD, Peter Rossing, DMSC, MD, Stefanie Eising, MD, Nicolai Larsen, MD, PHD, Christian Binder, DMSC, MD, Hans-Henrik Parving, DMSC, MD
Journal: Diabetes Care
Diabetes Care 2003;26(4):1258–1264
https://doi.org/10.2337/diacare.26.4.1258
Published: 01 April 2003
View article titled, Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Open the PDF for Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes in another window
Journal Articles

Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes

Peter Hovind, MD, Peter Rossing, DMSC, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2003;26(3):911–916
https://doi.org/10.2337/diacare.26.3.911
Published: 01 March 2003
View article titled, Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes
Open the PDF for Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes in another window
Journal Articles

Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: A 10-year prospective observational study

Peter Rossing, DMSC, Philip Hougaard, DSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2002;25(5):859–864
https://doi.org/10.2337/diacare.25.5.859
Published: 01 May 2002
View article titled, Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: <subtitle>A 10-year prospective observational study</subtitle>
Open the PDF for Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: <subtitle>A 10-year prospective observational study</subtitle> in another window